摘要
自2009年3月以来,首先发生在美国和墨西哥的新型甲型H1N1流感疫情迅速波及全球。中国科学家,包括流行病学家、病毒学家和临床医生深入研究疾病规律,并取得了可喜成绩。中国卫生部新型甲型H1N1流感专家组组长王辰教授领导课题组克服各种困难,及时总结了中国新型甲型H1N1流感早期病例的临床特征。他们发现,中国应对新发传染病的措施是及时有效的,病情早期的病例症状多数较轻,大约33%的患者没有发热症状,实时逆转录聚合酶链反应(PT-PCR)方法病毒核酸阳性持续中位时间约为6d。年龄小于14岁、男性、症状发生48h后才接受奥司他韦治疗均为病毒核酸持续检测阳性的独立危险因素。
In early April 2009, cases of human infection with novel influenza A pandemic （H1N1）2009 （ pandemic [ H1 N1 ] 2009） virus were identified in United States and Mexico and then spread rapidly to other regions of the world. Chinese scientists,including epidemiologists, virologists and clinical physicians worked hard on this new infectious disease. As the leader of National novel influenza A pandemic（ H1 N1 ）2009 Clinical Investigation Group of China, Dr. Chen Wang and his colleagues made important progress about the clinical features of the initial novel influenza A H1N1 2009 cases in China. They demonstrate that the public health response to curtail the spread of novel pandemic H1 N1 is prompt and effective in China. They found that most victims have a mild ill- ness,fever may be absent in 33% of cases,detection of influenza virus by rRT-PCR is typically 6 days（ whether or not fever is present）. An age 〈 14 years ,male sex,and onset-to-osehamivir interval 〉 48 hours are the independent risk factors for prolonged rRT-PCR pusitivity.
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2010年第1期4-5,共2页
Chinese Journal of Practical Internal Medicine
